Grace Therapeutics, Inc. (GRCE)

Net Change in Cash

-$3.22M

Quarterly · Period ending: · USD

GRCE logo

GRCE Net Change in Cash

Latest reported-$3.22M
GRCE Quarterly Net Change in Cash ($103.59K → -$3.22M)
High-resolution chart · PNG

GRCE net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-3,221,000
-1,695,000
1,810,000
-3,143,000
-2,128,000
11,078,000
-4,100,000
-4,239,000
-3,611,000
4,460,000
-8,446,000
5,358,000
-6,242,000
1,634,000
-8,685,000
-3,451,000
8,038,000
-2,674,000
-3,916,000
-4,046,000
-12,326,604
30,647,393
19,145,538
-758,444
-2,872,548
-7,658,039
271,000
3,519,000
-894,000
-4,346,053
16,830,759
-5,333,550
3,525,699
-4,615,007
5,682,703
-1,804,067
-1,695,423
-803,102
1,147,379
-1,254,351
-1,315,391
1,600,692
1,042,471
-68,981
-549,507
1,654,743
-255,116
-427,863
-2,059,113
1,530,624
332,646
-331,448
401,522
-333,621
-130,365
-355,915
1,472,055
-180,631
-91,655
86,308
-1,683,359
2,005,582
-251,743
-132,304
284,355
-80,013
-216,601
103,589
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.